Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
2004 1
2005 2
2010 1
2012 2
2016 1
2017 1
2018 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Small cell carcinoma ex-pleomorphic adenoma of the parotid gland.
Cimino-Mathews A, Lin BM, Chang SS, Boahene KD, Bishop JA. Cimino-Mathews A, et al. Head Neck Pathol. 2012 Dec;6(4):502-6. doi: 10.1007/s12105-012-0376-1. Epub 2012 Jun 27. Head Neck Pathol. 2012. PMID: 22736150 Free PMC article.
SCC is important to recognize because it often metastasizes widely and is treated with systemic chemotherapy. Carcinoma ex pleomorphic adenoma is a malignant epithelial neoplasm arising in a pre-existing benign mixed tumor (i.e., pleomorphic adenoma, P …
SCC is important to recognize because it often metastasizes widely and is treated with systemic chemotherapy. Carcinoma ex …
Mixed response and mechanisms of resistance to larotrectinib in metastatic carcinoma ex pleomorphic adenoma of the parotid harboring an NTRK2 fusion: A case report.
Pircher M, Briner HR, Bonomo M, Horcic M, Petrausch U, Helbling D, Winder T. Pircher M, et al. Medicine (Baltimore). 2021 Jan 29;100(4):e24463. doi: 10.1097/MD.0000000000024463. Medicine (Baltimore). 2021. PMID: 33530256 Free PMC article.
INTRODUCTION: Standardized systemic treatment options are lacking for carcinoma ex pleomorphic adenoma, which is a rare and aggressive tumor primarily found in salivary glands.Here we report the case of a 63-year-old male with carcinoma ex …
INTRODUCTION: Standardized systemic treatment options are lacking for carcinoma ex pleomorphic adenoma, which is …
Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine.
Sharon E, Kelly RJ, Szabo E. Sharon E, et al. Head Neck Oncol. 2010 May 26;2:12. doi: 10.1186/1758-3284-2-12. Head Neck Oncol. 2010. PMID: 20504363 Free PMC article.
BACKGROUND: Carcinoma ex pleomorphic adenoma is a rare histologic subtype of salivary gland cancer with an overall poor prognosis. ...CASE PRESENTATION: A 58 year old man presented with T1N2bM0 carcinoma ex pleomorphic adenoma …
BACKGROUND: Carcinoma ex pleomorphic adenoma is a rare histologic subtype of salivary gland cancer with an overa …
Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS-001 clinical trial.
Hernando-Calvo A, Malone E, Day D, Prawira A, Weinreb I, Yang SYC, Wong H, Rodriguez A, Jennings S, Eliason A, Wang L, Spreafico A, Siu LL, Hansen AR. Hernando-Calvo A, et al. Cancer Med. 2023 Oct;12(20):20299-20310. doi: 10.1002/cam4.6589. Epub 2023 Oct 11. Cancer Med. 2023. PMID: 37818869 Free PMC article.
SGT subtypes (WHO classification) included adenoid cystic carcinoma (n = 10), salivary duct carcinoma (n = 3), acinic cell carcinoma (n = 2), myoepithelial carcinoma (n = 2), carcinoma ex pleomorphic adenoma (n = 2) and other (n = 2). Of 18 evaluable p …
SGT subtypes (WHO classification) included adenoid cystic carcinoma (n = 10), salivary duct carcinoma (n = 3), acinic cell carcinoma (n = 2) …
RANK and RANK Ligand Expression in Parotid Gland Carcinomas.
Franchi A, Taverna C, Simoni A, Pepi M, Mannelli G, Fasolati M, Gallo O. Franchi A, et al. Appl Immunohistochem Mol Morphol. 2018 Aug;26(7):478-482. doi: 10.1097/PAI.0000000000000465. Appl Immunohistochem Mol Morphol. 2018. PMID: 29494398 Clinical Trial.
Formalin-fixed paraffin-embedded tumor samples from 46 consecutive cases of parotid gland carcinoma were selected for this study. For comparison, we examined a group of 40 randomly chosen parotid gland adenomas, including 20 pleomorphic adenomas, 10 myoepitheliomas, and 10 …
Formalin-fixed paraffin-embedded tumor samples from 46 consecutive cases of parotid gland carcinoma were selected for this study. For compar …
Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature.
Thorpe LM, Schrock AB, Erlich RL, Miller VA, Knost J, Le-Lindqwister N, Jujjavarapu S, Ali SM, Liu JJ. Thorpe LM, et al. Head Neck. 2017 Mar;39(3):E40-E44. doi: 10.1002/hed.24634. Epub 2016 Dec 22. Head Neck. 2017. PMID: 28006087 Review.
BACKGROUND: Salivary ductal carcinoma and carcinoma ex pleomorphic adenoma (CEPA) are aggressive salivary gland cancers with poor prognosis. ...
BACKGROUND: Salivary ductal carcinoma and carcinoma ex pleomorphic adenoma (CEPA) are aggressive salivary gland …
Carcinoma ex-pleomorphic adenoma of the breast. Report of three cases suggesting a relationship to metaplastic carcinoma of matrix-producing type.
Hayes MM, Lesack D, Girardet C, Del Vecchio M, Eusebi V. Hayes MM, et al. Virchows Arch. 2005 Feb;446(2):142-9. doi: 10.1007/s00428-004-1137-7. Epub 2004 Dec 4. Virchows Arch. 2005. PMID: 15583933
Three cases of carcinoma ex-pleomorphic adenoma of the breast are reported. Patients were 82, 60 and 56 years old and presented with a breast lump. ...
Three cases of carcinoma ex-pleomorphic adenoma of the breast are reported. Patients were 82, 60 and 56 years ol …
The impact of FDG-PET in the management of patients with salivary gland malignancy.
Otsuka H, Graham MM, Kogame M, Nishitani H. Otsuka H, et al. Ann Nucl Med. 2005 Dec;19(8):691-4. doi: 10.1007/BF02985118. Ann Nucl Med. 2005. PMID: 16444995 Clinical Trial.
Histology consisted of 8 adenocarcinomas, 8 squamous cell carcinomas, 4 adenoid cystic carcinomas, 4 carcinoma ex pleomorphic adenomas, 2 mucoepidermoid carcinomas, 2 poorly differentiated carcinomas, 1 salivary duct carcinoma, 1 lymphoepithelial carcinoma and 1 melanoma. PET fin …
Histology consisted of 8 adenocarcinomas, 8 squamous cell carcinomas, 4 adenoid cystic carcinomas, 4 carcinoma ex pleomorphic adenomas, 2 mu …
WT1 peptide therapy for a patient with chemotherapy-resistant salivary gland cancer.
Shirakata T, Oka Y, Nishida S, Hosen N, Tsuboi A, Oji Y, Murao A, Tanaka H, Nakatsuka S, Inohara H, Sugiyama H. Shirakata T, et al. Anticancer Res. 2012 Mar;32(3):1081-5. Anticancer Res. 2012. PMID: 22399636
Wilms' tumor (WT1) protein is one of the most promising target antigens for cancer immunotherapy. In fact, clinical responses, such as growth stabilization or shrinkage of tumor with immunological responses, have been reported in patients vaccinated with WT1 peptide. Here, …
Wilms' tumor (WT1) protein is one of the most promising target antigens for cancer immunotherapy. In fact, clinical responses, such a …
Karyotypic variability and evolutionary characteristics of a polymorphous low grade adenocarcinoma in the parotid gland.
Mark J, Wedell B, Dahlenfors R, Stenman G. Mark J, et al. Cancer Genet Cytogenet. 1991 Aug;55(1):19-29. doi: 10.1016/0165-4608(91)90230-r. Cancer Genet Cytogenet. 1991. PMID: 1913603
The characteristics of the marker sets suggested a closely interrelated derivation of the subclones. The results also provide insight as to the influence of random factors and/or differential growth rate on the chromosomal picture observed in in vitro systems. The present …
The characteristics of the marker sets suggested a closely interrelated derivation of the subclones. The results also provide insight as to …